5:11 PM ET
8-K
Nasdaq/NYSE Compliance Notice
Annovis Bio Nasdaq/NYSE Compliance Notice
Annovis Bio received a deficiency notice from the NYSE for failing to maintain a minimum average market capitalization of $50 million and stockholders' equity of $50 million over a 30-day period. The company has 45 days to submit a compliance plan and 9 months to regain compliance to avoid delisting. During this period, the stock will continue to trade under the symbol 'ANVS' with an added '.BC' designation.
- Counterparty
- NYSE
- Term
- 9 months